查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375903

誘導性多功能幹細胞（iPS 細胞）生產市場規模、佔有率和趨勢分析報告：按工藝、按工作流程、按產品、按應用、按最終用途、按地區和細分趨勢，2023-2030 年

Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Reprogramming, Cell Culture), By Product, By Application (Regenerative Medicine), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

誘導性多功能幹細胞（iPS 細胞）生產市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，預計到2030年，全球誘導性多功能幹細胞生產市場規模將達到27.6億美元。

預計2023年至2030年該市場將以9.3%的年複合成長率擴張。與誘導性多功能幹細胞）的需求不斷成長，顯著推動了市場的發展。幹細胞不存在倫理問題、個體化治療的可能性以及細胞研究的彈性等優勢為市場成長創造了有利的前景。此外，慢性病的流行也推動了誘導性多功能幹細胞生產市場的成長。這是因為心臟病、中風、糖尿病和許多其他疾病都可以使用 iPS 細胞介導的療法來治療。例如，根據國際糖尿病聯盟 (IDF) 的數據，到 2021 年，將有 5.37 億人患有糖尿病。

COVID-19 大流行期間研究活動的增加對市場產生了積極影響。由於 SARS CoV-2 感染已導致患者患有多種疾病，因此這次疫情大流行刺激了許多領域的研究。例如，2021年4月，美國研究人員表示，高達25%的COVID-19患者患有心臟功能障礙。透過他們的研究論文，他們證明了 SARS CoV-2 是由將 iPS 細胞衍生的心臟細胞暴露於 SARS CoV-2 引起的，並且在患者的人體屍檢標本中也證實了類似的變化。這些見解使得能夠使用誘導性多功能幹細胞(iPSC) 作為開發藥物和治療方法的平台，以控制 COVID-19 的長期影響。

誘導誘導性多功能幹細胞是源自成體細胞的細胞，並進一步重新編程以獲得類似 ESC 的多功能。事實證明，這些 iPS 細胞對於使用 ESC 進行研究來說是一個在倫理上合理的選擇。倫理爭議最激烈，因為胚胎幹細胞的產生涉及破壞胚囊階段的胚胎。然而，誘導性多功能幹細胞僅透過對體細胞進行基因重編程，就解決了研究中破壞人類胚胎的倫理問題。這推動了市場成長，並帶來了藥物研發、疾病建模和毒性測試等眾多應用。例如，2021年8月，Fate Therapeutics宣布臨床試驗中首例FT819患者接受治療。 FT819是一種源自iPS細胞的人工CAR-T細胞療法。由於其獨特的特性，如可再生潛力和免疫調節特性，研究界越來越關注探索誘導性多功能幹細胞在再生醫學中的應用，從而推動了市場的擴張。

誘導性多功能幹細胞生產市場報告亮點

  • 從製程來看，手動iPSC製造流程佔據市場主導地位，2022年佔最大銷售佔有率，為77.2%。
  • 從工作流程來看，細胞培養部門在市場中佔據主導地位，2022 年佔銷售額的最大佔有率為 37.3%。細胞培養工作流程包括來自 iPSC 收穫產品、擴增產品和分化產品的收益，有助於提高該細分市場的市場相關性。
  • 按產品分類，消耗品和套件細分市場佔據主導地位，2022 年佔據最大銷售佔有率，達到 40.3%。 iPSC 領域的持續研發活動正在推動對各種消耗品和試劑盒的需求。
  • 按應用分類，藥物研發與發現領域佔最大銷售佔有率，2022年為43.3%。
  • 按最終用途分類，生物技術和製藥公司細分市場佔據主導地位，2022 年收益佔有率最高，達 59.3%。各種試劑盒、消耗品和儀器以及 iPSC 產品的可用性和採用正在推動該領域的產生收入。
  • 北美地區主導市場，2022 年收益佔有率最大，達 40.8%。該地區慢性病患病率不斷上升、醫療基礎設施發達、公共和私人項目的資金以及戰略商業模式正在推動市場產生收入。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 誘導性多功能幹細胞生產市場變數、趨勢與範圍

  • 市場體系展望
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 誘導性多功能幹細胞生產市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 誘導性多功能幹細胞的製造：依製程進行的估算與趨勢分析

  • 誘導性多功能幹細胞生產市場：重點
  • 誘導性多功能幹細胞生產市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 手動 iPSC 生產流程
    • 2018 年至 2030 年手動 iPSC 生產製程市場估計與預測
  • 自動化 iPSC 生產流程
    • 2018年至2030年自動化iPSC生產流程市場估計與預測

第5章 誘導性多功能幹細胞的製造：透過工作流程進行估算與趨勢分析

  • 誘導性多功能幹細胞生產市場：重點
  • 誘導性多功能幹細胞生產市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 重新程式設計
  • 細胞培養
  • 細胞表徵/分析
  • 工程
  • 其他

第6章 誘導性多功能幹細胞的生產：依產品估算與趨勢分析

  • 誘導性多功能幹細胞生產市場：重點
  • 誘導性多功能幹細胞生產市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 設備/設備
    • 2018年至2030年設備及設備市場預測
  • 自動化平台
    • 2018年至2030年自動化平台市場預測
  • 消耗品/套件
    • 2018 年至 2030 年消耗品和套件的市場估計和預測
    • 培養基
    • 成套工具
    • 其他
  • 服務
    • 2018年至2030年服務市場估計與預測

第7章 誘導性多功能幹細胞的產生：應用的估計和趨勢分析

  • 誘導性多功能幹細胞生產市場：重點
  • 誘導性多功能幹細胞生產市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 藥物研發/發現
  • 再生醫學
  • 毒理學研究
  • 其他

第8章 誘導性多功能幹細胞的生產：最終用途的估計和趨勢分析

  • 誘導性多功能幹細胞生產市場：重點
  • 誘導性多功能幹細胞生產市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 研究/學術機構
    • 2018年至2030年研究和學術機構的市場估計和預測
  • 生物技術和製藥公司
    • 2018年至2030年生物技術和製藥公司的市場估計和預測
  • 醫院/診所
    • 2018 年至 2030 年醫院和診所的市場估計和預測

第9章 誘導性多功能幹細胞的生產：各地區的估算與趨勢分析

  • 區域展望
  • 按地區分類的誘導性多功能幹細胞生產市場：關鍵市場點
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第10章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Lonza
    • Axol Biosciences Ltd.
    • Evotec Se
    • Hitachi Ltd.
    • Reprocells Inc.
    • Fate Therapeutics
    • Thermo Fisher Scientific, Inc.
    • Merck Kgaa
    • StemCellsFactory III
    • Applied StemCells, Inc.
Product Code: GVR-4-68039-549-7

Induced Pluripotent Stem Cells Production Market Growth & Trends:

The global induced pluripotent stem cells production market size is estimated to reach USD 2.76 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 9.3% from 2023 to 2030. The increase in demand for induced pluripotent stem cells (iPSCs) in comparison to Embryonic Stem Cells (ESCs) has offered a significant drive to the market. Advantages such as no stem cell-related ethical issues, personalized treatment, and flexibility during cell-based research have created a favorable scenario for market growth. In addition, the prevalence of chronic disorders is also driving the growth of the induced pluripotent stem cells production market, as conditions like heart disease, stroke, diabetes, and many more can be treated by utilizing iPSCs-mediated therapy. For example, according to the International Diabetes Federation (IDF), 537 million people are already living with diabetes in 2021.

The rising research activities during COVID-19 pandemic have positively impacted the market. The pandemic fueled research in many fields as the SARS CoV-2 infection resulted in many diseases in the patients. For instance, in April 2021, researchers from USA stated that up to 25% of COVID-19 patients suffered cardiac dysfunction. Through their research article, they demonstrated the pathogenesis via exposure of iPSCs-derived cardiac cells to SARS CoV-2, and similar alterations were confirmed from human autopsy specimens of the patients. Such insights allow the use of induced pluripotent stem cells (iPSCs) as drug or therapy development platforms and their utilization in the management of the long-term effects of COVID-19.

Induced pluripotent stem cells are cells that are derived from adult somatic cells and then further reprogrammed to obtain the pluripotency as that of ESCs. These iPSCs are proving to be an ethically uncomplicated alternative for research that involves ESCs. The derivation of the ESCs is associated with the destruction of an embryo at the blastocyte stage, which has led to a maximum number of ethical debates. However, induced pluripotent stem cells have solved the ethical issue over the destruction of human embryos in research by involving only the genetic reprogramming of somatic cells. This has propelled the market growth and resulted in numerous applications including drug discovery, disease modeling, toxicology testing, and many others. For instance, in August 2021, Fate Therapeutics announced the treatment of the first patient with FT819 during clinical trials. FT819 is an engineered CAR-T cell therapy that is derived from iPSCs. Also, the rising focus of the research community on exploring applications of induced pluripotent stem cells in regenerative medicine due to their unique characteristics such as differential potential, self-renewable, immunomodulatory properties, and others; is set to drive the market expansion.

Induced Pluripotent Stem Cells Production Market Report Highlights:

  • By process, the manual iPSC production process segment dominated the market and accounted for the largest revenue share of 77.2% in 2022.
  • By workflow, the cell culture segment dominated the market with the largest revenue share of 37.3% in 2022. Cell culture workflow is inclusive of revenues generated from iPSC harvest products, expansion products, and differentiation products; thus contributing to the market relevance of this segment.
  • By product, the consumables and kits segment dominated the market and accounted for the largest revenue share of 40.3% in 2022. The never-ceasing research and development activities in the iPSCs space are driving the demand for various consumables & kits.
  • By application, drug development & discovery segment dominated the market with the largest revenue share of 43.3% in 2022.
  • By end-user, the biotechnology and pharmaceutical companies segment dominated the market with the largest revenue share of 59.3% in 2022. The availability and adoption of various kits, consumables, and instruments along with iPSCs products are driving the revenue generation in this segment.
  • North America dominated the market and accounted for the largest revenue share of 40.8% in 2022. The growing incidence of chronic diseases in this region, developed healthcare infrastructure, funds from private & government initiatives, and strategic business models are driving the revenue generation in the marketspace.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Process
    • 1.1.2. Workflow
    • 1.1.3. Product
    • 1.1.4. Application
    • 1.1.5. End use
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Process outlook
    • 2.2.2. Workflow outlook
    • 2.2.3. Product outlook
    • 2.2.4. Application outlook
    • 2.2.5. End use outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Induced Pluripotent Stem Cells Production Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Induced Pluripotent Stem Cells Production Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Induced Pluripotent Stem Cells Production: Process Estimates & Trend Analysis

  • 4.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
  • 4.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Manual iPSC Production Process
    • 4.3.1. Manual iPSC production process market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Automated iPSC Production Process
    • 4.4.1. Automated iPSC production process market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Induced Pluripotent Stem Cells Production: Workflow Estimates & Trend Analysis

  • 5.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
  • 5.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Reprogramming
    • 5.3.1. Reprogramming market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Cell Culture
    • 5.4.1. Cell culture market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Cell Characterization / Analysis
    • 5.5.1. Cell characterization / analysis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Engineering
    • 5.6.1. Engineering market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Induced Pluripotent Stem Cells Production: Product Estimates & Trend Analysis

  • 6.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
  • 6.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Instruments/ Devices
    • 6.3.1. Instruments/ devices market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Automated Platforms
    • 6.4.1. Automated platforms market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Consumables & Kits
    • 6.5.1. Consumables & kits market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.2. Media
      • 6.5.2.1. Media market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.3. Kits
      • 6.5.3.1. Kits market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.4. Others
      • 6.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Services
    • 6.6.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Induced Pluripotent Stem Cells Production: Application Estimates & Trend Analysis

  • 7.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
  • 7.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Drug Development & Discovery
    • 7.3.1. Drug development & discovery market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Regenerative Medicine
    • 7.4.1. Regenerative medicine market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Toxicology Studies
    • 7.5.1. Toxicology studies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Induced Pluripotent Stem Cells Production: End Use Estimates & Trend Analysis

  • 8.1. Induced Pluripotent Stem Cells Production Market: Key Takeaways
  • 8.2. Induced Pluripotent Stem Cells Production Market: Movement & Market Share Analysis, 2022 & 2030
  • 8.3. Research & Academic Institutes
    • 8.3.1. Research & academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4. Biotechnology & Pharmaceutical Companies
    • 8.4.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. Hospitals & Clinics
    • 8.5.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Induced Pluripotent Stem Cells Production: Regional Estimates & Trend Analysis

  • 9.1. Regional Outlook
  • 9.2. Induced Pluripotent Stem Cells Production Market by Region: Key Marketplace Takeaway
  • 9.3. North America
    • 9.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.4. Europe
    • 9.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.2. UK
      • 9.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.4. France
      • 9.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.8. Norway
      • 9.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.9. Denmark
      • 9.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.3. China
      • 9.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.4. India
      • 9.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.7. South Korea
      • 9.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.6.3. Mexico
      • 9.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.6.4. Argentina
      • 9.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.7. MEA
    • 9.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.3. South Africa
      • 9.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Market Participant Categorization
    • 10.2.1. Lonza
      • 10.2.1.1. Company overview
      • 10.2.1.2. Financial performance
      • 10.2.1.3. Product benchmarking
      • 10.2.1.4. Strategic initiatives
    • 10.2.2. Axol Biosciences Ltd.
      • 10.2.2.1. Company overview
      • 10.2.2.2. Financial performance
      • 10.2.2.3. Product benchmarking
      • 10.2.2.4. Strategic initiatives
    • 10.2.3. Evotec Se
      • 10.2.3.1. Company overview
      • 10.2.3.2. Financial performance
      • 10.2.3.3. Product benchmarking
      • 10.2.3.4. Strategic initiatives
    • 10.2.4. Hitachi Ltd.
      • 10.2.4.1. Company overview
      • 10.2.4.2. Financial performance
      • 10.2.4.3. Product benchmarking
      • 10.2.4.4. Strategic initiatives
    • 10.2.5. Reprocells Inc.
      • 10.2.5.1. Company overview
      • 10.2.5.2. Financial performance
      • 10.2.5.3. Product benchmarking
      • 10.2.5.4. Strategic initiatives
    • 10.2.6. Fate Therapeutics
      • 10.2.6.1. Company overview
      • 10.2.6.2. Financial performance
      • 10.2.6.3. Product benchmarking
      • 10.2.6.4. Strategic initiatives
    • 10.2.7. Thermo Fisher Scientific, Inc.
      • 10.2.7.1. Company overview
      • 10.2.7.2. Financial performance
      • 10.2.7.3. Product benchmarking
      • 10.2.7.4. Strategic initiatives
    • 10.2.8. Merck Kgaa
      • 10.2.8.1. Company overview
      • 10.2.8.2. Financial performance
      • 10.2.8.3. Product benchmarking
      • 10.2.8.4. Strategic initiatives
    • 10.2.9. StemCellsFactory III
      • 10.2.9.1. Company overview
      • 10.2.9.2. Financial performance
      • 10.2.9.3. Product benchmarking
      • 10.2.9.4. Strategic initiatives
    • 10.2.10. Applied StemCells, Inc.
      • 10.2.10.1. Company overview
      • 10.2.10.2. Financial performance
      • 10.2.10.3. Product benchmarking
      • 10.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 3 North America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 4 North America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
  • Table 8 U.S. induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 9 U.S. induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 10 U.S. induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 14 Canada induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 15 Canada induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 16 Canada induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 17 Canada induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Europe induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 19 Europe induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 20 Europe induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Europe induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
  • Table 24 Germany induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 25 Germany induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 26 Germany induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 27 Germany induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 29 UK induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 30 UK induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 31 UK induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 32 UK induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 33 UK induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 34 France induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 35 France induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 36 France induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 37 France induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 38 France induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Italy induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 40 Italy induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 41 Italy induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 43 Italy induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Spain induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 45 Spain induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 46 Spain induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 47 Spain induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Sweden induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 50 Sweden induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 51 Sweden induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 52 Sweden induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 53 Sweden induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Norway induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 55 Norway induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 56 Norway induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 57 Norway induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 58 Norway induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Norway induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 60 Denmark induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 61 Denmark induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 62 Denmark induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 63 Denmark induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
  • Table 70 China induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 71 China induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 72 China induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 73 China induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 74 China induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Japan induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 76 Japan induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 77 Japan induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 78 Japan induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 79 Japan induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 80 India induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 81 India induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 82 India induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 83 India induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 84 India induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Australia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 86 Australia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 87 Australia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 88 Australia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 89 Australia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Thailand induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 91 Thailand induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 92 Thailand induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 93 Thailand induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 94 Thailand induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 95 South Korea induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 96 South Korea induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 97 South Korea induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 98 South Korea induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 99 South Korea induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 100 Latin America induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 101 Latin America induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 102 Latin America induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 103 Latin America induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 104 Latin America induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 105 Latin America induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
  • Table 106 Brazil induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 107 Brazil induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 108 Brazil induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 109 Brazil induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 110 Brazil induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Mexico induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 112 Mexico induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 113 Mexico induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 114 Mexico induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 115 Mexico induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 116 Argentina induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 117 Argentina induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 118 Argentina induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 119 Argentina induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 120 Argentina induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 121 Middle East and Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 122 Middle East and Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 123 Middle East and Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 124 Middle East and Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 125 Middle East and Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 126 Middle East and Africa induced pluripotent stem cells production market, by region, 2018 - 2030 (USD Million)
  • Table 127 South Africa induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 128 South Africa induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 129 South Africa induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 130 South Africa induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 131 South Africa induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 137 UAE induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 138 UAE induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 139 UAE induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 140 UAE induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 141 UAE induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)
  • Table 142 Kuwait induced pluripotent stem cells production market, by process, 2018 - 2030 (USD Million)
  • Table 143 Kuwait induced pluripotent stem cells production market, by workflow, 2018 - 2030 (USD Million)
  • Table 144 Kuwait induced pluripotent stem cells production market, by product, 2018 - 2030 (USD Million)
  • Table 145 Kuwait induced pluripotent stem cells production market, by application, 2018 - 2030 (USD Million)
  • Table 146 Kuwait induced pluripotent stem cells production market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Induced pluripotent stem cells production: Market outlook
  • Fig. 8 Induced pluripotent stem cells production: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Induced pluripotent stem cells production market driver impact
  • Fig. 14 Induced pluripotent stem cells production market restraint impact
  • Fig. 15 Induced pluripotent stem cells production market strategic initiatives analysis
  • Fig. 16 Induced pluripotent stem cells production market: Process movement analysis
  • Fig. 17 Induced pluripotent stem cells production market: Process outlook and key takeaways
  • Fig. 18 Manual iPSC production process estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Automated iPSC production process estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Induced pluripotent stem cells production market: Workflow movement analysis
  • Fig. 21 Induced pluripotent stem cells production market: Workflow outlook and key takeaways
  • Fig. 22 Reprogramming market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Cell characterization / analysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Induced pluripotent stem cells production market: Product movement analysis
  • Fig. 28 Induced pluripotent stem cells production market: Product outlook and key takeaways
  • Fig. 29 Instruments/ devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Automated platforms market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Consumables & kits market estimates and forecasts, 2018 - 2030
  • Fig. 32 Media market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Induced pluripotent stem cells production market: Application movement analysis
  • Fig. 37 Induced pluripotent stem cells production market: Application outlook and key takeaways
  • Fig. 38 Drug development and discovery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Regenerative medicine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Toxicology studies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030
  • Fig. 42 Induced pluripotent stem cells production market: End use movement analysis
  • Fig. 43 Induced pluripotent stem cells production market: End use outlook and key takeaways
  • Fig. 44 Research & academic institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Global Induced pluripotent stem cells production market: Regional movement analysis
  • Fig. 48 Global Induced pluripotent stem cells production market: Regional outlook and key takeaways
  • Fig. 49 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)